万维提示：
1、投稿方式：官网投稿。
2、期刊网址：
https://www.sciencedirect.com/journal/journal-of-thoracic-oncology
3、投稿网址：
https://www.editorialmanager.com/jto/default1.aspx
4、官网邮箱：
mary.todd@iaslc.org（主编）
5、官网电话：1-720-325-2947
6、期刊刊期：月刊，一年出版12期。
2022年01月10日星期一
投稿须知【官网信息】
JOURNAL OF THORACIC ONCOLOGY
Scope
Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. The audience consists of epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.
Publication Goal
Time to first decision: approximately 7 days
Acceptance to online publication: 3-5 days
Acceptance to print publication: approximately 3 months
Types of Paper
Original Articles:
Our intent is to publish high quality research as it relates to clinical trials, outcome analyses, translational research, cost utility analyses, etc.
These articles should adhere to the following parameters:
250-word structured abstract
4,000 words of text
6 tables and/or figures
50 references
There is no limit for Supplemental Digital Content. This also applies to all other article types for this journal.
Brief Reports:
Articles having a maximum of 1500 words, up to 3 tables and/or figures and an abstract with a highly focused message and minimum of methodological detail, and maximum of 15 references. Include "Brief Report:" in the title.
Editorials/Views/Commentaries:
Should not exceed 1500 words with no more than 15 references.
Review Articles:
Will be mostly by invitation. Prospective authors are urged to contact the editors prior to submitting uninvited reviews. These articles should be no longer than 4000 words with no more than 75 references and may include up to 6 tables and/or figures.
Image(s) or Case(s) of the Month:
Emphasis is on the images. Include up to 5 exceptional images with one or two short paragraphs of text.
Gene or Pathway of the Month:
Maximum of 1000 words plus 1 or 2 illustrations covering genes or pathways important in development or treatment of thoracic malignancies. There should be no more than 15 references.
Case Reports:
Reports highlighting unusual presentations of malignancy, treatment outcome, toxicity, etc. Submissions must be a total of 1000 words or less and may include up to 3 figures and/or tables and no more than 5 references. Authors are encouraged to submit images and /or photographs which support the case being illustrated. The journal follows the CARE guidelines (for CAse REports) to enhance accuracy, transparency, and usefulness of case reports. Authors are required to include the following information in case reports:
Title - The diagnosis or intervention of primary focus followed by the words "case report".
Key Words - 2 to 5 key words that identify diagnoses or interventions in this case report (including "case report").
Disclosure Statement of Conflict of Interest
Abstract - (structured or unstructured)
Introduction - What is unique about this case and what does it add to the scientific literature?
The patient's main concerns and important clinical findings.
The primary diagnoses, interventions, and outcomes.
Conclusion - What are one or more "take-away" lessons from this case report?
Introduction - Briefly summarizes why this case is unique and may include medical literature references.
Patient Information
De-identified patient specific information.
Primary concerns and symptoms of the patient.
Medical, family, and psychosocial history including relevant genetic information.
Relevant past interventions and their outcomes.
Informed Consent - Statement of patient's informed consent is required.
Clinical Findings - Describe significant physical examination (PE) and important clinical findings.
Timeline - Historical and current information from this episode of care organized as a timeline (figure or table).
Diagnostic Assessment
Diagnostic methods (PE, laboratory testing, imaging, surveys).
Diagnostic challenges.
Diagnosis (including other diagnoses considered).
Prognostic characteristics when applicable.
Therapeutic Intervention
Types of therapeutic intervention (pharmacologic, surgical, preventive).
Administration of therapeutic intervention (dosage, strength, duration).
Changes in therapeutic interventions with explanations.
Follow-up and Outcomes
Clinician- and patient-assessed outcomes if available.
Important follow-up diagnostic and other test results.
Intervention adherence and tolerability. (How was this assessed?)
Adverse and unanticipated events.
Discussion
Strengths and limitations in your approach to this case.
Discussion of the relevant medical literature.
The rationale for your conclusions.
Conclusion
The primary "take-away" lessons from this case report (without references) in a one paragraph conclusion.
References - Appropriately chosen references from the peer-reviewed scientific literature.
Acknowledgement - A short acknowledgement section should mention funding support, if applicable.
……
更多详情：
https://www.elsevier.com/journals/journal-of-thoracic-oncology/1556-0864/guide-for-authors
